A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease (Q46724666)
Jump to navigation
Jump to search
scientific article published on 27 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease |
scientific article published on 27 January 2014 |
Statements
1 reference
A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease (English)
1 reference
William J Sandborn
1 reference
Subrata Ghosh
1 reference
Julian Panes
1 reference
Ivana Vranic
1 reference
Wenjin Wang
1 reference
Wojciech Niezychowski
1 reference
Study A3921043 Investigators
1 reference
27 January 2014
1 reference
12
1 reference
9
1 reference
1485-93.e2
1 reference
Identifiers
1 reference
1 reference